2012•Medical Journal of Chinese People's HealthRequires access

Effect evaluation of Aripiprazole combined with Venlafaxine in the treatment of Major depressive disorder

Fei Yuan-fang

Open publisher page 1 citations

Abstract

Objective:To observe the efficacy and safety of Aripiprazole combined with Venlafaxine in the treatment of major depressive disorder.Methods:56 patients with major depression disorder were randomly divided into observation group(28 cases) and control group(28 cases),Aripiprazole and Venlafaxine were used in observation group,and Venlafaxine was only used in control group,treatment for 8 weeks.All the patients were evaluated with HAMD,HAMA,clinical global impression scale(CGI-SI) and treatment emergent symptom scale(TESS) before treatment and at the end of 1st,2nd,4th,8th week.Results:Two groups of HAMD and HAMA score after 8 weeks of treatment than before treatment differences were significant((t=2.13,1.32,P0.01);the differences of HAMD scores of 2nd,6th,8th weeks and HAMA scores of 2nd,6th weeks between the two groups were significant(t=2.03~3.00,P0.05~0.01);total clinical effective rate in observation group(82%) was significantly better than that in control group(57%)(χ2=4.139,P0.05);Two groups of TESS score difference was significant((t=2.42,P0.05).Conclusion:Aripiprazole combined with Venlafaxine is effective and safe in the treatment of major depressive disorder.

About this research paper

What this paper is about

Objective:To observe the efficacy and safety of Aripiprazole combined with Venlafaxine in the treatment of major depressive disorder.Methods:56 patients with major depression disorder were randomly divided into observation group(28 cases) and control group(28 cases),Aripiprazole and Venlafaxine were used in observation group,and Venlafaxine was only used in control group,treatment for 8 weeks.All the patients were evaluated with HAMD,HAMA,clinical global impression scale(CGI-SI) and treatment emergent symptom scale(TESS) before treatment and at the end of 1st,2nd,4th,8th week.Results:Two groups of HAMD and HAMA score after 8 weeks of treatment than before treatment differences were significant((t=2.13,1.32,P0.01);the differences of HAMD scores of 2nd,6th,8th weeks and HAMA scores of 2nd,6th weeks between the two groups were significant(t=2.03~3.00,P0.05~0.01);total clinical effective rate in observation group(82%) was significantly better than that in control group(57%)(χ2=4.139,P0.05);Two groups of TESS score difference was significant((t=2.42,P0.05).Conclusion:Aripiprazole combined with Venlafaxine is effective and safe in the treatment of major depressive disorder.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To observe the efficacy and safety of Aripiprazole combined with Venlafaxine in the treatment of major depressive disorder.Methods:56 patients with major depression disorder were randomly divided into observation group(28 cases) and control group(28 cases),Aripiprazole and Venlafaxine were used in observation group,and Venlafaxine was only used in control group,treatment for 8 weeks.All the patients were evaluated with HAMD,HAMA,clinical global impression scale(CGI-SI) and treatment emergent symptom scale(TESS) before treatment and at the end of 1st,2nd,4th,8th week.Results:Two groups of HAMD and HAMA score after 8 weeks of treatment than before treatment differences were significant((t=2.13,1.32,P0.01);the differences of HAMD scores of 2nd,6th,8th weeks and HAMA scores of 2nd,6th weeks between the two groups were significant(t=2.03~3.00,P0.05~0.01);total clinical effective rate in observation group(82%) was significantly better than that in control group(57%)(χ2=4.139,P0.05);Two groups of TESS score difference was significant((t=2.42,P0.05).Conclusion:Aripiprazole combined with Venlafaxine is effective and safe in the treatment of major depressive disorder.

Key concepts: Aripiprazole, Hamd, Venlafaxine, Hamilton depression scale, Major depressive disorder, Clinical Global Impression, Internal medicine, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source